Tags
Blog

'neuroscience' posts

Swedish MS Center represented at Congress of the European Committee for the Treatment and Research in MS

The 29th Congress of the European Committee for the Treatment and Research in MS (ECTRIMS) and the 18th Annual Conference on Rehabilitation in MS (RIMS) were held on October 2-5 in Copenhagen, Denmark. These two meetings are the largest scientific meetings on MS and rehabilitation in MS, with over 8,000 people attending this year.

The MS Center at Swedish was well-represented with five people attending. The meeting consisted of educational courses, symposia and scientific research presentations. The scientific presentations included over 1200 posters describing recent research in MS. There were also over 200 oral scientific research presentations. Upcoming blog posts will cover some of the reports that were of most interest to us.

Trigeminal Neuralgia: Face Pain & Treatment Options

October 7th was Trigeminal Neuralgia Awareness Day and for many reading or hearing the stories, like the story on CNN.com, this condition may not be familiar.  However, for those suffering from trigeminal neuralgia, every day can be challenging.

Facial pain in Trigeminal Neuralgia is characterized by episodes of intense pain lasting from a few seconds to hours at a time. The attacks are often described as electric shock like, burning, pressing, crushing,  or shooting pain. Patients describe areas on the face as sensitive to the point that even a gentle breeze of wind can trigger an episode of pain.

Once diagnosed, trigeminal neuralgia can be treated with ...

Wondering how a service dog may help you?

It’s our pleasure to announce that Buddy Hayes will be coming to the MS Center on October 21! Buddy is a motivational speaker who’s passionate about educating the public on the daily challenges that people with disabilities face and how they overcome them. She is a retired certified therapeutic recreation specialist as well as a veteran of the US Army.

Buddy has been living with multiple sclerosis for many years and she’s turned her diagnosis into an opportunity to change the way that the world perceives people with disabilities. Buddy has shown that she is not only an inspirational speaker, but she’s also unafraid to take on any challenge. Just a few of her many accomplishments include skiing, rock climbing, surfing, scuba diving, and winning the title of Ms. Wheelchair Virginia 2007-2008. One of the many ways that Buddy takes on challenges is with the help of her service dog, Stanford.

On October 21, Buddy (and Stanford) will be coming to the MS Center to talk about what a service dog is, how to obtain one, and how they can change a life forever.

We welcome all who’d like to attend Buddy’s presentation:

October 21st 1:00-2:00 pm
Hedreen Wellness Studio, MS Center
Jefferson Tower, Level A

Quality of Life Following CyberKnife Treatment for Prostate Cancer

The Swedish Radiosurgery Center is the lead site in a national multi-institutional study evaluating CyberKnife for treating men with intermediate-risk prostate cancer (clinical stage 2). As the principal investigator of this study, I reported on the quality of life outcomes at the annual meeting of American Society of Radiation Oncology.

We now know that in low-risk prostate cancer patients (stage 1), active surveillance is a safe option. But men with intermediate-risk cancer have a significant risk of dying of their disease, so intervention is necessary. Conventional treatments (surgery, radioactive seed implants and external beam radiotherapy) can adversely affect patients’ quality of life.  We sought to determine if the unprecedented accuracy of CyberKnife treatment would translate into improvement in these patients’ quality of life.

We treated ..

New MS therapy approved by the European Commission

On September 17, the European Commission, the European equivalent of the US Food and Drug Administration (FDA), approved the release of alemtuzumab (Lemtrada™.)

Alemtuzumab is an intravenous monoclonal antibody that selectively reduces circulating T lymphocytes, which are thought to be involved in inflammation in multiple sclerosis (MS). This reduction is followed by repopulation of T and B cells over time. It is administered on five consecutive days in the first year of therapy, followed by three consecutive days 12 months later.

Swedish Neuroscience Institute was involved in Care-MS II, one of the pivotal Phase III studies in which MS patients who had relapsed on other therapies were randomized to either alemtuzumab or interferon beta-1a. The drug was found to be significantly ...

Team Swedish Bikes for Multiple Sclerosis

The Swedish S’myelin Babes, Swedish’s Bike MS team, raised more than $46,000 this year. The annual event raises funds for multiple sclerosis research and local programs to support people living with the disease.

Check out a few photos captured by Dr. Lily JungHenson from this year’s event:

Brain Aneurysm Awareness: Spreading the Word

September is National Brain Aneurysm Awareness Month and across the country, those affected by various forms of the disease raise awareness through fundraising and visibility events. Bringing a voice to the disease may seem daunting in a sea of awareness ribbons and weekend community walks—but  Swedish had the opportunity to focus a spotlight on Seattle as host for the Brain Aneurysm Foundation’s Annual Symposium. This Massachusetts-based organization is the nation’s only not-for-profit profit organization solely dedicated to providing critical awareness, education, support and research funding to reduce the incidence of brain aneurysms. Swedish Neuroscience Institute physicians teamed up with other elite physicians from across the country and others in the medical community, in addition to volunteers and Brain Aneurysm Foundation members to learn more about advances in research for the disease.

One unique component to this important event was the attendance of members of the Swedish Cerebrovascular Support Group. The group, established in 2012, brings together patients, family members and caregivers to share their experiences, with the goal of alleviating fears and concerns through education and group discussions...

Results 71-77 of 100